Skip to main content
Premium Trial:

Request an Annual Quote

Ayers is Genomica's New CEO, Marr Still Presides

Premium

BOULDER, Colo.--Teresa Ayers is the new CEO at Genomica, a pharmacogenomics software company. She will work together with Thomas Marr, who continues as president, chief scientist, and director of Genomica. Ayers had been president and chief executive officer of BioStar, a manufacturer and marketer of in vitro human diagnostic tests. Before that, she was chief financial officer of CytRx, a publicly traded biotech company; Biopool, a publicly traded human diagnostic business; and Plasti-Line, a publicly traded signage firm. Genomica was founded by Marr in 1996 as a way to market the tools he and his team developed at Cold Spring Harbor Laboratory in New York.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.